5. Green chemistry is a pro-active
approach to pollution prevention
It targets pollution at the design
stage, before it even begins.
It is designing chemical produts
and processes that reduce or
eliminate the use and the
generation of hazardous
substances.
6. PRINCIPLES OF GREEN
CHEMISTRY
Waste reduction in chemical synthesis
Using rawmaterials and feedstocks
from renewable sources
Employing catalysts.
Avoiding chemical derivatives.
Maximising atom economy
7. Replacing or reducing solvents.
Increasing energy efficiency of
chemical reactions
Using in-process or real time
monitoring.
Other process safety and
environmental consideration.
8.
9. GREEN CHEMISTRY IN
PHARMACEUTICAL
Currently,the pharma industry is trying
to curb spending in the industry.
Green chemistry offers significant cost
advantages.
Compared with other sectors in its
green practices,the pharma ranks low
The E-factor
10.
11. AMERICAN CHEMICAL SOCIETY GREEN
CHEMISTRY INSTITUTE [ACSGCI]
In 2005,several firms along with
ACSGCI established the GCI
Phrmaceutical Round table
[ACSGCIPR].
The major companies included in this
are
Pfizer,Johnson&Johnson, Astrazeneca,
GalaxoSmithKline etc.
They reviewed work in 14 areas.
12. THE AREAS REVIEWED BY
ACSGCIPR
Solvent reduction or replacement.
Oxidation
Amide formation
Assymetric hydrogenations
Flourination
Carbon-hydrogen activation
Bio catalysis
Chemistry in water
Alcohol activation for nucleophilic displacem’t
Friedel-crafts chemistry
Continous processing intensification
Supercritical fluid chromatography separation
13. GSK’S ECO-DESIGN TOOL KIT
A Green chemistry &technological guide
A material guide to solvents & bases with
related environmental health &safety data
A fast lifecycle assesment for synthetic
chemistry that streamlines evaluations of
environmental lifecycle & measures green
metrics
A green packaging guide
A guide that identifies legislation phasing out
hazardous substances
14. SOME HIGH PROFILE SUCCESSES IN
PHARMACEUTICAL INDUSTRY
Rochebetters route for Pyridinylimadazole –
based drug.
Merck’s green process for Raltegravir
Pfizer’s green synthesis of Pregabalin
Eli
Lilly optimizes production of neurokinin-1
antagonist